PPD in the News
Sponsors already heeding FDA’s call for diversity planning, experts say
Rose Blackburne comments on the FDA’s guidance on trial diversity planning.
Chief Learning Officer reveals 2022 LearningElite award winners
The PPD clinical research business of Thermo Fisher Scientific was named a 2022 LearningElite silver award winner for its exemplary workforce development strategies that deliver significant business results.
Positioning the patient in drug trials
The authors discuss how the clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials.
When is it appropriate to outsource bioanalysis work to a CRO?
Amy Lavelle and Laura Brunner discuss the factors to assess, such as type of work, regulatory considerations and the study’s needs.
CRO market insights
Company thought leaders discuss the impact of COVID and regulatory frameworks for clinical trials today.
The role of implementation leads in successful FSP projects
Brian Ford notes that making an FSP model work takes coordination and accountability, which is where an implementation lead can prove valuable.
PPD and Matrix Clinical Trials team on decentralized study tech
Collaboration demonstrates Thermo Fisher’s continuing commitment to advance decentralized trial solutions for customers and patients.
Paving the way to better inhaled drug delivery
Christopher Gruenloh comments on the state of play for inhaled drugs and how the pharmaceutical laboratory is evolving to accommodate new development.
Thermo Fisher announces mobile clinical research collaboration
Innovative decentralized clinical trial solution to help identify, recruit and retain trial participants.
